Trial intelligence / Profile preview

Itraconazole prophylaxis for invasive fungal infection after induction chemotherapy in AML

TCTR20160113001Phase 3Recruiting

Sponsor
Siriraj Oncology Foundation
Start
Jun 2015
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 3 trial of itraconazole in acute myeloid leukemia (AML), invasive mycoses, sponsored by Siriraj Oncology Foundation. Started Jun 2015; status: recruiting.

02

Drugs

itraconazole
03

Conditions

acute myeloid leukemia (AML)invasive mycoses

Beyond the preview

Go deeper on TCTR20160113001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20160113001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call